ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 71 filers reported holding ALBIREO PHARMA INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $2,066,988 | +61.8% | 78,029 | 0.0% | 0.28% | -11.0% |
Q1 2020 | $1,277,335 | -35.6% | 78,029 | 0.0% | 0.32% | -9.1% |
Q4 2019 | $1,983,497 | +450.1% | 78,029 | +332.8% | 0.35% | +212.5% |
Q3 2019 | $360,580 | -38.0% | 18,029 | 0.0% | 0.11% | -31.3% |
Q2 2019 | $581,255 | +0.1% | 18,029 | 0.0% | 0.16% | -3.6% |
Q1 2019 | $580,714 | +31.3% | 18,029 | 0.0% | 0.17% | -29.3% |
Q4 2018 | $442,251 | -25.6% | 18,029 | 0.0% | 0.24% | -8.4% |
Q3 2018 | $594,236 | -7.2% | 18,029 | 0.0% | 0.26% | -10.9% |
Q2 2018 | $640,030 | +9.0% | 18,029 | 0.0% | 0.29% | +7.3% |
Q1 2018 | $587,205 | – | 18,029 | – | 0.27% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 1,704,330 | $60,504,000 | 1.59% |
Birchview Capital, LP | 38,000 | $1,349,000 | 0.92% |
Virtus ETF Advisers LLC | 24,688 | $876,000 | 0.77% |
BVF INC/IL | 220,000 | $7,810,000 | 0.76% |
SECTORAL ASSET MANAGEMENT INC | 172,803 | $6,135,000 | 0.69% |
Chicago Capital, LLC | 134,748 | $4,784,000 | 0.39% |
Artal Group S.A. | 500,000 | $17,750,000 | 0.38% |
TPG Group Holdings (SBS) Advisors, Inc. | 716,381 | $25,432,000 | 0.33% |
Eversept Partners, LP | 18,029 | $640,030 | 0.29% |
HEARTLAND ADVISORS INC | 125,000 | $4,438,000 | 0.29% |